Cervical cancer, the most common cancer affecting women in developing countries, is
caused by persistent infection with" high-risk" genotypes of human papillomaviruses (HPV) …

Worldwide, cervical cancer is the second most common cancer of women. Less-developed
countries bear the greatest burden in terms of morbidity and mortality, largely due to the lack …

Benign and malignant disease caused by HPV (human papillomavirus) constitutes a global
public health problem. Genital warts are the commonest viral sexually transmitted infection …

Oncogenic human papillomavirus (HPV) infection is the cause of nearly all cervical cancers
and a proportion of other anogenital and oropharyngeal cancers. A bivalent vaccine …

Human papillomavirus (HPV) is the most common sexually transmitted infection in the
United States, and persistent HPV infection is strongly associated with risk of cervical cancer …

Vaccination against human papillomavirus (HPV) promises to dramatically decrease the
incidence of HPV-related diseases, including cervical cancer. Although this vaccine is …

Candidate prophylactic vaccines based on papillomavirus L1 virus-like particles (VLPs) are
currently in human clinical trials. The main long-term goal of the vaccine is to reduce the …

Human papillomavirus (HPV) is the most common sexually transmitted infection, with 15
HPV types related to cervical, anal, oropharyngeal, penile, vulvar, and vaginal cancers …

Human papillomavirus (HPV) is the most common sexually transmitted infectious agent; its
14 oncogenic types are causally associated with 5–10% of all cancers. The major structural …

At least 15 types of HPV have been associated with cervical cancer, but current HPV
vaccines confer only type‐specific immunity. To determine geographic variations in the HPV …